| Description: |
The sulphonamides are competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle and have a bacteriostatic effect on a broad range of Gram-positive and Gram-negative organisms. The sulphonamides are distributed widely throughout all organs and tissues; and are metabolized primarily by the liver, producing inactive acetylated and glucuronide forms, which are excreted in urine (28).
Sulphonamides are used extensively in veterinary medicine and their use in food producing animals could result in potentially harmful concentrations in tissue, organs and milk. The potential risk is reduced by withdrawal of the drug for a fixed period before slaughter, although residual levels may still remain.
|
| Application:
|
The antibody is suitable for the development of immunoassays or immunoaffinity purification
columns.
|
| Buffer:
|
20mM Phosphate, 150mM Sodium Chloride, pH 7.2
|
| Footer:
|
For in vitro use only, research applications not intended for diagnostic or therapeutic purposes
|
| Format:
|
Ig fraction
|
| Host:
|
Sheep
|
| Ig Con:
|
7.77 mg/ml (U.V. abs at 280nm)
|
| Immunogen:
|
Sulphatroxazole-BTG
|
| Lot:
|
RS1320-03
|
| Preservative:
|
0.09% Sodium Azide
|
| Related:
|
Sulphatroxazole -HRP Cat. No. HRP9417, size 0.5 ml
|
| Sensitivity:
|
10 ng/ml sulphatroxazole produces 25%
inhibition in a competitive ELISA, employing
sulphatroxazole polyclonal antibody.
|
| Specificity:
|
Data not yet available.
|
| Storage:
|
≤ -20C, avoid repeated freeze/thaw cycles
|
| Work Con:
|
1.25 μg/ml (ELISA microtitre platebased)
|
| References:
|
28. The Merck Manual of Diagnosis and Therapy, Chapter 153: Antibacterial Drugs.
|
| Datasheet: |
|
